These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date, and reported results Terminated 2004-002966-39 A Double-blind randomised controlled trial to compare buscopan versus placebo as an adjunct to colonoscopy bad-data
Reported results 2004-003843-28 The acute effects of testosterone administration in patients with pulmonary hypertension 2009-09-01 due-trials
Reported results Terminated 2004-003844-24 The effects of testosterone therapy in men with pulmonary hypertension 2006-04-11 due-trials
Reported results 2005-000027-42 The effect of testosterone therapy on angina threshold and atheroma in patients with stable angina 2008-05-20 due-trials
Reported results 2005-000049-12 The effects of testosterone therapy in men with pulmonary hypertension 2006-07-20 due-trials
Reported results 2005-002096-32 A randomised controlled clinical trial of metformin versus orlistat for the management of obses anovulatory women 2007-12-08 due-trials
Completed, but no date, and reported results Terminated 2005-005446-39 Pilot study of a dose-adjusted regimen of tiroban during percutnaeous coronary intervention bad-data
Reported results 2006-000833-36 The Action of Botox® on Urgency – A precise evaluation of its impact on urodynamic parameters during bladder filling in patients with non-neurogenic Overactive Bladder (OAB). 2011-07-01 due-trials
Reported results 2006-001090-23 Testosterone therapy as an adjunct to exercise rehabilitation: effects on exercise capacity, inflammatory markers and quality of life in hypogonadal males with chronic heart failure. 2009-12-18 due-trials
Reported results Terminated 2006-004389-15 The use of Single dose intravenous paracetamol "Perfalgan" in Early extubation cardiac surgery 2011-04-04 due-trials
Reported results 2006-004738-33 Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects. Subtitle: A 2-year randomised parallel group trial of alendronate, ibandronate and risedronate for postmenopau... 2013-02-25 due-trials
Completed, but no date, and reported results Terminated 2006-004846-17 A randomised, placebo controlled trial of the efficacy of the addition of spironolactone to modern antihypertensive treatment regimes in patients with resistant hypertension. bad-data
Reported results Terminated 2006-005471-18 Topical Capsaicin 0.025% as a treatment for Achilles tendinopathy. A prospective, double blinded, randomised controlled trial with multiple outcome measures. 2009-09-10 due-trials
Reported results 2007-001159-20 A Prospective, Multi-centre, Single-Arm, Open Label Study of the Long term Use of a LHRH Agonist (Decapeptyl® SR, 11.25 mg) in Combination with Livial® Add-back Therapy in the Management of Chronic Cy... 2016-05-09 due-trials
Reported results 2007-001187-78 The 3Mg Trial: A randomised controlled trial of intravenous or nebulised magnesium sulphate versus standard therapy for acute severe asthma 2012-07-25 due-trials
Reported results 2007-001526-27 ANZAC: A Randomised Phase II Feasibility Study Investigating The Biological Effects of the Addition of Zoledronic Acid To Neoadjuvant Comnination Chemotherapy On Invasive Breast Cancer 2010-01-05 due-trials
Reported results 2007-007604-15 A Pilot Study of the Effect of Glucocorticoid Receptor Antagonism in Patients with Sub-Clinical Cushing's Syndrome 2010-05-04 due-trials
Reported results 2008-006007-23 A clinicopathological phase II study of axitinib in patients with advanced angiosarcoma and other soft tissue sarcomas 2019-01-08 due-trials
Reported results 2009-014457-33 An Open Label, Longitudinal Study of the Effects of Subcutaneous Acute and Chronic Pasireotide (SOM230) Therapy on Adrenocorticotrophic Hormone and Tumour Volume in Patients with Nelson's Syndrome. 2015-09-24 due-trials
Reported results 2010-021009-19 Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action. A two year open label single arm study of teriparatide in secondary care. 2015-08-21 due-trials
Other 2010-021165-76 STOMP: Small cell lung cancer Trial of Olaparib (AZD2281) as Maintenance Programme: a randomised, double blind, multicentre phase II trial not-yet-due
Reported results 2010-023198-21 The Relative Effectiveness of Pumps Over MDI and Structured Education. 2015-06-25 due-trials
Other 2011-000541-20 Effect of Denosumab on Osteolytic Lesion Activity in Total Hip Arthroplasty (THA) not-yet-due
Reported results 2011-000677-31 Testosterone Replacement in Young Male cancer Survivors 2015-12-06 due-trials
Exempt 2011-003099-35 Phase I/II study of oral MEK inhibitor Selumetinib (AZD6244 Hyd-Sulphate) in Combination with Highly Active Anti-Retroviral Therapy (HAART) in AIDS-associated Kaposi’s sarcoma (KS). 2018-06-30 not-yet-due
Reported results 2011-003320-12 Study of the effect of morphine on prasugrel absorption in patients with prior history of ST elevation myocardial infarction 2013-03-31 due-trials
Reported results Terminated 2011-006019-73 Randomized, double blind, placebo-controlled trial of Creon in patients with low faecal pancreatic elastase 2014-08-12 due-trials
Reported results 2012-002564-27 Pilot open study of testosterone replacement in non-alcoholic steatohepatitis 2017-01-30 due-trials
Reported results 2012-003342-33 Optimising the use of Entonox during screening colonoscopy: an open randomised controlled trial 2014-04-08 due-trials
Reported results 2012-005514-18 Study of the Effect of Ticagrelor and Clopidogrel on the Immune Response of Healthy Volunteers 2014-01-10 due-trials
Reported results 2013-002505-62 SarCaBon: A randomised phase II trial of Saracatinib versus placebo for cancer-induced bone pain 2018-01-24 due-trials
Reported results 2013-004837-34 Lung HeXeRT: Advanced proton, hyperpolarised 3helium and 129xenon magnetic resonance imaging for lung cancer radiotherapy planning and evaluation 2019-08-08 due-trials
Reported results 2014-001924-31 Exploring novel mechanisms of vaccine failure and induction of pulmonary immunity following live attenuated influenza vaccination in HIV infected and uninfected individuals: a pilot study. 2015-06-15 due-trials
Other 2014-002112-16 Analysis of the immune response to Fendrix as compared to double-dose Engerix B in HIV-infected non-responders to standard Hepatitis B vaccination courses not-yet-due
Reported results 2014-004783-38 Study of two regimens of TicagrElor compared to clopidogrel in patients undergoing ELective Percutaneous Coronary Intervention (STEEL PCI) 2018-05-31 due-trials
Other 2015-002269-47 Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy. not-yet-due
Reported results 2016-000920-25 A study of very low dose twice-daily compared to standard low dose once-daily aspirin following acute coronary syndromes - WILL lOWer dose aspirin be more effective following ACS? 2017-01-20 due-trials
Reported results 2016-002964-15 The Effect of Selenium Supplementation on Musculoskeletal Health in Older Women Double-blind, randomised, placebo-controlled trial 2020-01-31 due-trials
Other 2017-002435-42 DANTE: A randomised phase III trial to evaluate the Duration of ANti-PD1 monoclonal antibody Treatment in patients with metastatic mElanoma not-yet-due
Reported results 2018-000774-30 Prolonged ENoxapariN in primarY percutaneous coronary intervention compared WIth Standard-of-carE therapy: Feasibility study (PENNYWISE Feasibility) 2020-03-09 due-trials
No trial status on register 2018-000991-13 The MAGIC trial (Melatonin for Anxiety prior to General anaesthesia In Children): A Multicentre, Parallel Randomised Controlled Trial of Melatonin Versus Midazolam in the Premedication of Anxious Chil... bad-data
Other 2018-001887-46 A Phase II, Placebo Controlled, Double Blind, Randomised Clinical Trial to assess the safety and tolerability Of 30mg/kg daily Ursodeoxycholic Acid (UDCA) in Patients with Parkinson’s Disease (PD) not-yet-due
Exempt 2018-003620-37 NEPTUNE: Enhancement of immuNothEraPy combining avelumab and repeaT doses of radiUm-223 in ER+ve, HER2-ve metastatic breast caNcEr. not-yet-due
Other 2018-004285-34 The impact of aspirin dose modification on the innate immune response - WILL lOWer dose aspirin Therapy ReducE the response to Endotoxin? – (WILLOW TREE) not-yet-due
Other 2019-000267-25 Characterisation of a novel regimen of very low-dose aspirin combined with rivaroxaban in patients with chronic coronary syndromes: WILL lOWer dose aspirin be better with rivaroxaban in patients with ... not-yet-due
Other 2019-001549-42 A multicentre, randomised controlled trial to evaluate the efficacy of autologous haematopoietic stem cell transplantation versus alemtuzumab or ocrelizumab in relapsing remitting multiple sclerosis. not-yet-due
Other 2019-002643-23 Validation of a novel composite of skin biomarkers as a primary outcome measure for evaluating the safety of treatments for atopic dermatitis: a randomized controlled trial (phase 2) comparing the eff... not-yet-due